Project Details
Projekt Print View

Repräsentation im Arbeitsgedächtnis und Kodierung von Neuheit bei der paranoid-halluzinatorischen Schizophrenie

Subject Area Clinical Neurology; Neurosurgery and Neuroradiology
Term from 2006 to 2011
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 21480453
 
Final Report Year 2011

Final Report Abstract

No abstract available

Publications

  • (2008) Mesolimbic interaction of emotional valence and reward improves memory formation. Neuropsychologia 46(4), 1000-8
    Wittmann, B. C., K. Schiltz, C. N. Boehler and E. Duzel
  • 2009. Gestörte Kodierung von Neuheit bei der Schizophrenie. Abstract book of DGPPN Congress 2009, Berlin, Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde, S.114.
    Schulte-Kemna, A., K. Zierhut, B. Bogerts and K. Schiltz
  • 2010. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. European Archives of Psychiatry and Clinical Neuroscience, Vol. 260. 2010, Issue 7, pp. 509–518.
    Steiner J, Jacobs R, Panteli B, Brauner M, Schiltz K, Bahn S, Herberth M, Westphal S, Gos T, Walter M, Bernstein H, Myint AM, & Bogerts B.
    (See online at https://dx.doi.org/10.1007/s00406-010-0098-x)
  • 2010. Elevated S100B levels in schizophrenia are associated with insulin resistance. Molecular Psychiatry, Vol. 15. 2010, Issue 1, pp. 3–4.
    Steiner J, Walter M, Guest P, Myint AM, Schiltz K, Panteli B, Brauner M, Bernstein H, Gos T, Herberth M, Schroeter ML, Schwarz MJ, Westphal S, Bahn S, & Bogerts B.
    (See online at https://dx.doi.org/10.1038/mp.2009.87)
  • 2010. Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience, Vol. 167. 2010, Issue 4, pp. 1025–1031.
    Steiner J, Schroeter ML, Schiltz K, Bernstein HG, Müller UJ, Richter-Landsberg C, Müller WE, Walter M, Gos T, Bogerts B, & Keilhoff G.
    (See online at https://dx.doi.org/10.1016/j.neuroscience.2010.03.010)
  • 2010. S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance. Cardiovascular psychiatry and neurology, Vol. 2010 (2010), Article ID 480707, 11 pages.
    Steiner J, Myint AM, Schiltz K, Westphal S, Bernstein H, Walter M, Schroeter ML, Schwarz MJ, & Bogerts B.
    (See online at https://dx.doi.org/10.1155/2010/480707)
  • 2010. The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Research: Neuroimaging, Vol. 183. 2010, Issue 3, pp. 187–194.
    Zierhut K, Bogerts B, Schott B, Fenker D, Walter M, Albrecht D, Steiner J, Schütze H, Northoff G, Düzel E, & Schiltz K.
    (See online at https://dx.doi.org/10.1016/j.pscychresns.2010.03.007)
  • P03-125 - Memory dysfunction and defective novelty detection in schizophrenia: 18th European Congress of Psychiatry. February 27, March 2, 2010 - Munich, Germany. In European Psychiatry, Vol. 25. 2010, Supplement 1, pp. 1105–1105.
    Schiltz K, Zierhut KC, & Bogerts B.
  • PW01-157 - Mesolimbic dysfunction during novelty detection in schizophrenia: 18th European Congress of Psychiatry. February 27, March 2, 2010 - Munich, Germany. European Psychiatry, Vol. 25. 2010, Supplement 1, pp. 1573.
    Zierhut K, Schulte-Kemna A, Bogerts B, & Schiltz K.
  • 2013. Distinct structural alterations independently contributing to working memory deficits and symptomatology in paranoid schizophrenia. Cortex, Vol. 49. 2013, Issue 4, pp. 1063–1072.
    Zierhut KC, Schulte-Kemna A, Kaufmann J, Steiner J, Bogerts B, & Schiltz K.
    (See online at https://doi.org/10.1016/j.cortex.2012.08.027)
  • 2013. Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia. Brain : a journal of neurology, Vol. 136. 2013, Issue 3, pp. 804–814.
    Zierhut KC, Graßmann R, Kaufmann J, Steiner J, Bogerts B, & Schiltz K.
    (See online at https://doi.org/10.1093/brain/aws335)
  • 2013. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry, Vol. 70. 2013, Issue 3, pp. 271-278.
    Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein H, Vielhaber S, Kästner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger K, Bogerts B, & Stoecker W.
    (See online at https://dx.doi.org/10.1001/2013.jamapsychiatry.86)
  • 2014. Absence of dopamine receptor serum autoantibodies in schizophrenia patients with an acute disease episode. Schizophrenia Research, Vol. 158. 2014, Issues 1–3, pp. 272–274.
    Müller UJ, Teegen B, Probst C, Bernstein H, Busse S, Bogerts B, Schiltz K, Stoecker W, & Steiner J.
    (See online at https://dx.doi.org/10.1016/j.schres.2014.06.025)
 
 

Additional Information

Textvergrößerung und Kontrastanpassung